XERF vs Thermage: What Is the Difference?
Oct 02, 2026
XERF vs Thermage: What Is the Difference?
XERF and Thermage belong to the non-invasive monopolar radiofrequency category used for tissue remodeling and skin tightening.
This makes the comparison different from XERF versus RF microneedling.
Both deliver RF from the skin surface without microneedles, but the systems differ in device design, frequencies, energy management, cooling and treatment protocols.
There is currently no published direct clinical trial demonstrating that XERF or Thermage is universally superior.
What is Thermage?
Thermage is an established monopolar RF platform with a relatively long history in aesthetic dermatology.
It uses RF energy to produce controlled tissue heating while protecting the skin surface.
Its longer period of clinical use means that monopolar RF systems including Thermage have a broader historical evidence base than XERF.
What is XERF?
XERF is a newer monopolar RF platform using two frequencies, 6.78 MHz and 2 MHz.
The dual frequency design is intended to produce different patterns of thermal distribution within tissue.
The system also incorporates surface cooling during treatment.
Are both treatments needle free?
Yes.
Both are non-invasive monopolar RF technologies.
They do not insert microneedles as RF microneedling does, and they do not introduce a subdermal fiber as Endolift does.
Why do different frequencies matter?
Frequency can influence electrical and thermal distribution within tissue, but it is not the only factor determining treatment outcome.
XERF uses 6.78 MHz and 2 MHz.
Computational and preclinical dual-frequency research suggests that 2 MHz can create broader and deeper thermal distribution than 6.78 MHz.
Frequency alone, however, cannot determine which device will produce a better clinical result.
Electrode design, energy, pulse delivery, cooling, tissue thickness and technique all influence treatment response.
Which is better for facial tightening?
There is currently no direct XERF versus Thermage trial that can answer this scientifically.
Clinical evidence supports monopolar RF as a general category.
Thermage has a longer clinical history, while XERF has newer early clinical studies reporting encouraging outcomes.
Comparing outcomes from separate studies using different populations and protocols is not equivalent to a direct comparative trial.
What do we know about Thermage scientifically?
Monopolar RF has a relatively long research history in skin tightening.
Systematic reviews have found measurable improvement in skin laxity following non-invasive RF in appropriately selected patients.
Thermage has also been used as an active comparator in recent randomized studies evaluating newer monopolar RF technologies.
What do we know about XERF scientifically?
XERF specific evidence is newer.
Early human studies have reported improvement in facial laxity and patient satisfaction.
Computational and histological studies also support frequency dependent thermal distribution and collagen and elastin remodeling.
Sample sizes and long term follow up remain limited.
Does XERF reach deeper than Thermage?
This question requires caution.
XERF studies can describe observed patterns of thermal distribution, but there is currently insufficient direct human comparative evidence demonstrating that XERF universally treats a clinically deeper level than Thermage.
Deeper also does not automatically mean better.
The objective is appropriate energy delivery to the tissue requiring treatment while maintaining safety.
Which requires fewer sessions?
Thermage is frequently used clinically as a single treatment followed by reassessment, although treatment planning varies.
Current XERF studies have used one session in one study and two sessions in another.
There is no direct trial establishing that either technology universally requires fewer treatments.
When do results appear?
Both rely on controlled thermal effects and tissue remodeling.
Some change may be observed early, while other changes develop during subsequent weeks and months.
Collagen remodeling is not an instantaneous process.
How long do results last?
Longer historical data exist for monopolar RF and Thermage than for XERF.
Long term XERF specific evidence remains limited.
Marketing durations should therefore not be interpreted as guaranteed longevity for every patient.
Natural aging continues following either treatment.
Which is more comfortable?
Both systems use strategies to manage skin surface temperature and patient comfort.
Actual sensation depends on device design, energy, treatment protocol, anatomical area and individual sensitivity.
There is currently insufficient direct evidence to state that XERF is universally more comfortable than Thermage.
What about downtime?
Both technologies are non-invasive.
Recovery is therefore generally limited compared with procedures that penetrate the skin.
Temporary erythema, edema or sensitivity may occur following monopolar RF treatment.
Is XERF the new generation of Thermage?
That description is not medically precise.
XERF and Thermage are separate technologies from different manufacturers that share the monopolar RF category.
A newer launch date does not establish that one is a scientifically proven upgraded version of another.
Is newer automatically better?
No.
Time on the market does not determine clinical efficacy.
A newer technology may offer different technical features, while an established technology may have a larger evidence base and longer follow up.
Clinical outcomes rather than novelty should guide evaluation.
Can XERF be performed after Thermage or vice versa?
A patient may potentially undergo another RF treatment in the future when there is an appropriate indication.
Previous treatment, tissue response, timing and cumulative thermal exposure should be considered.
Using two similar technologies simply because both are available is not a treatment objective.
What does the scientific evidence show?
Recent systematic reviews support RF, including monopolar RF, for selected facial rejuvenation and skin laxity indications with predominantly transient adverse effects.
Recent randomized research has also used Thermage as an active monopolar RF comparator and demonstrated measurable improvement after treatment.
XERF has newer direct clinical studies with smaller populations and shorter follow up.
A direct XERF versus Thermage clinical trial is not currently available.
The bottom line
XERF and Thermage are both non-invasive monopolar RF technologies, but they are not identical systems.
XERF uses a dual-frequency approach with 6.78 MHz and 2 MHz, while Thermage has a longer clinical and research history.
Current evidence does not establish universal superiority of either device.
Diagnosis, device quality, treatment parameters, practitioner expertise and realistic treatment goals are more meaningful than device novelty alone.
Frequently asked questions
Is XERF stronger than Thermage?
There is no direct clinical evidence establishing this, and greater technical power does not necessarily equal a better clinical outcome.
Are both treatments needle free?
Yes. Both use non-invasive monopolar RF.
Which has more clinical evidence?
Monopolar RF and Thermage have a longer research history, while XERF specific evidence is newer and currently smaller.
Can I have XERF if I previously had Thermage?
It may be appropriate in selected patients following assessment, but the decision should depend on current anatomy, previous response and timing rather than device name alone.
This content is intended for medical education and general patient information. Treatment selection should be based on individual medical assessment.
